Cerebrospinal fluid analyses in migraine patients and controls

scientific article

Cerebrospinal fluid analyses in migraine patients and controls is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1046/J.1468-2982.1995.1506489.X
P698PubMed publication ID8706112

P2093author name stringT L Yaksh
J F Rothrock
A C Moore
A Golbeck
K R Mar
P2860cites workOn serotonin and migraine: a clinical and pharmacological reviewQ28263827
Taurine levels in plasma and cerebrospinal fluid in migraine patientsQ34729562
Evidence for a role of the N-methyl-D-aspartate (NMDA) receptor in cortical spreading depression in the rat.Q41338044
Suboccipital cerebrospinal fluid and plasma concentrations of somatostatin, neuropeptide Y and beta-endorphin in patients with common migraineQ43613895
Platelet Glycine, Glutamate and Aspartate in Primary HeadacheQ46199099
Evidence of alpha-N-acetyl beta-endorphin in human cerebrospinal fluidQ48454865
Endorphin patterns within the headache spectrum disordersQ48493897
A pharmacological investigation of cerebro-spinal fluid from patients with migraineQ51201127
Excretion of free and conjugated 5-HIAA and VMA in urine and concentration of 5-HIAA and HVA in CSF during migraine attacks and free intervalsQ53939422
Monosodium L-glutamate: its pharmacology and role in the Chinese restaurant syndrome.Q55062025
Cerebrospinal fluid gamma aminobutyric acid levels in migraineQ55154931
P433issue6
P407language of work or nameEnglishQ1860
P921main subjectcerebrospinal fluidQ54196
migraineQ133823
P304page(s)489-493
P577publication date1995-12-01
P1433published inCephalalgiaQ5063251
P1476titleCerebrospinal fluid analyses in migraine patients and controls
P478volume15

Reverse relations

cites work (P2860)
Q28834117A 'complex' of brain metabolites distinguish altered chemistry in the cingulate cortex of episodic migraine patients
Q53329143Aminergic tone correlates of migraine and tension-type headache: a study using the tridimensional personality questionnaire.
Q38121110Biomarkers associated with migraine and their potential role in migraine management
Q37801392Brain Imaging in Migraine Research
Q36546364Cerebrospinal fluid biomarkers in primary headache disorders
Q45021407Cerebrospinal fluid glutamate levels in chronic migraine
Q41460262Clinical studies of valproate for migraine prophylaxis
Q34124786Effects of ionotropic glutamate receptor antagonists on rat dural artery diameter in an intravital microscopy model
Q37271327Excitatory neurotransmitters in brain regions in interictal migraine patients
Q35658661Genotype-phenotype correlation in migraine without aura focusing on the rs1835740 variant on 8q22.1.
Q56618727Increased Cerebrospinal Fluid Glycine: A Biochemical Marker for a Leukoencephalopathy With Vanishing White Matter
Q41572995Interactions between the Kynurenine and the Endocannabinoid System with Special Emphasis on Migraine
Q38140024Is the migrainous brain normal outside of acute attacks? Lessons learned from psychophysical, neurochemical and functional neuroimaging studies
Q45304283Metabolic assessment of a migraine model using relaxation-enhanced 1 H spectroscopy at ultrahigh field
Q39297448Metabolomic changes in CSF of migraine patients measured with 1H-NMR spectroscopy
Q44919937Monoaminergic transmitters in the cerebrospinal fluid of patients with acute, chronic, and intermittent pain. Interface between pain and depression?
Q37140513Neurometabolic effects of ACTH on free amino compounds in opsoclonus-myoclonus syndrome
Q37394217Neuropeptide changes and neuroactive amino acids in CSF from humans and sheep with neuronal ceroid lipofuscinoses (NCLs, Batten disease).
Q52090356Patterns of functional brain organization and migraine.
Q36546368Selected confirmed, probable, and exploratory migraine biomarkers.
Q57021546What Are We Missing in the Diagnostic Criteria for Migraine?
Q34372024What's in a name? tension-type headache versus migraine